Skip to main content

MoneyWorks4Me

FDC - Quaterly Results

28 Oct 2026 Evaluate
The revenue for the September 2026 quarter is pegged at Rs. 5527.90 millions, about 19.72% up against Rs. 4617.40 millions recorded during the year-ago period.Handsome Net Profit growth of 61.77% reported above the corresponding previous quarter figure of Rs. 476.90 millions to Rs. 294.80 millions.Operating profit surged to 803.10 millions from the corresponding previous quarter of 558.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 5527.90 4617.40 19.72 12078.90 11040.20 9.41 21263.27 20701.12 2.72
Other Income 186.20 209.10 -10.95 659.60 565.00 16.74 1110.01 1055.18 5.20
PBIDT 803.10 558.10 43.90 2704.90 2327.30 16.22 4631.81 4257.65 8.79
Interest 8.30 11.50 -27.83 16.50 23.10 -28.57 49.24 44.88 9.71
PBDT 794.80 546.60 45.41 2688.40 2304.20 16.67 4374.68 4212.77 3.84
Depreciation 159.50 151.70 5.14 310.40 300.40 3.33 591.04 536.06 10.26
PBT 635.30 394.90 60.88 2378.00 2003.80 18.67 3783.64 3676.71 2.91
TAX 158.40 100.10 58.24 580.90 487.00 19.28 924.40 940.46 -1.71
Deferred Tax -5.00 -9.90 -49.49 20.50 27.00 -24.07 61.40 90.46 -32.12
PAT 476.90 294.80 61.77 1797.10 1516.80 18.48 2859.24 2736.25 4.49
Equity 162.80 162.80 0.00 162.80 162.80 0.00 162.81 162.81 0.00
PBIDTM(%) 14.53 12.09 20.20 22.39 21.08 6.23 21.78 20.57 5.91
Peers
Company Name CMP
Sun Pharma. Inds. 1762.00
Dr. Reddys Labs. 1357.70
Cipla 1381.20
Lupin 2015.50
Zydus Lifesciences 1250.00
View more..